Search
Dare Bioscience Inc
DAREAdd to Watchlist
2.110USD
0.0000.00%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
31.61MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-01The current earnings forecast score of Dare Bioscience Inc is 8.00, ranking 56 out of 157 in the Pharmaceuticals industry. The average price target is 11.50, with a high of 12.00 and a low of 8.00.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
10.250
Target Price
+385.78%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
177
Total
6
Median
8
Average
Company name
Ratings
Analysts
Dare Bioscience Inc
DARE
3
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
Vertex Pharmaceuticals Inc
VRTX
34
AbbVie Inc
ABBV
33
1
2
3
...
36
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Dare Bioscience Inc's price target?
Analysts forecast that Dare Bioscience Inc's price target is USD 11.50, with the highest forecast at USD 12.00 and the lowest forecast at USD 8.00.
How have Dare Bioscience IncDARE's recent earnings per share performed?
The market expectation was USD -0.21, while Dare Bioscience IncDARE's earnings per share (EPS) for the previous quarter was USD -0.10. EPS for the next quarter is expected at USD -0.24.
What is the analyst rating for Dare Bioscience Inc?
Based on the ratings of Dare Bioscience Inc's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.